Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid
Clinical trial NCT02226146 · COMPLETED
Trial details
- NCT number
- NCT02226146
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-29
- Primary completion
- 2018-04-30
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.